Preparing for Regulatory Review and Reimbursement Decisions: A Case for Cooperation between Regulatory Authorities, Sponsors and Health Technology Assessment Agencies

Author： Liberti Lawrence E.   Pichler Franz   Walker Stuart R.  

Publisher： Adis International

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.23, Iss.5-6, 2009-10, pp. : 263-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Criticism of an IVF clinic and regulatory agencies in a case of mixed-race twins

By  

Reproductive BioMedicine Online, Vol. 9, Iss. 2, 2004-08 ,pp. : 151-151

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

US FDA regulatory decisions

By  

Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Recent FDA regulatory decisions

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Essentiality and Toxicity in Copper Health Risk Assessment: Overview, Update and Regulatory Considerations

By Stern Bonnie Ransom  

Journal of Toxicology and Environmental Health, Vol. 73, Iss. 2-3, 2010-01 ,pp. : 114-127

Taylor & Francis Ltd

Access to resources Recommend Favorite

Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions: The Case for Reference Models

By >   Karnon Jonathan  

PharmacoEconomics, Vol. 29, Iss. 10, 2011-10 ,pp. : 823-825

Adis International

Access to resources Recommend Favorite